DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development.
Mandarano AH, Harris TL, Creasy BM, Wehenkel M, Duggar M, Wilander BA, Mishra A, Crawford JC, Mullen SA, Williams KM, Pillai M, High AA, McGargill MA.
Mandarano AH, et al. Among authors: harris tl.
Cell Rep. 2023 Feb 28;42(2):112106. doi: 10.1016/j.celrep.2023.112106. Epub 2023 Feb 13.
Cell Rep. 2023.
PMID: 36773294
Free PMC article.